{"acquisitions":[],"changes":[],"country":"US","description":"Neuron23 is a clinical-stage biotech company developing precision medicines for neurological and immunological diseases, with a focus on Parkinson's. It serves patients with genetically defined disease such as LRRK2-driven Parkinson's. Its differentiator is machine-learning-based patient selection to find people most likely to respond.","domain":"neuron23.com","employees":null,"founded":2016,"fundingTotalQuarantined":false,"githubOrg":"neuron23","githubStars":null,"industry":"unknown","industrySources":[],"investors":[],"lat":37.65354,"lng":-122.416866,"location":"South San Francisco, United States","multiples":[],"name":"Neuron23","people":[],"revenues":[],"rounds":[{"amountQuarantined":false,"amountUsd":96500000,"connectionsAmong":[],"currency":"USD","date":"2025-06-01","investments":[],"investors":[],"leadInvestor":null,"leadInvestors":[],"people":[],"slug":"neuron23-com-2025-06-01-series-b","source":{"fact":"round","publisher":"crunchbase","retrievedAt":"2026-06-05","status":"attributed","url":null},"status":"attributed","type":"series-d+","url":null}],"slug":"neuron23-com","sources":[{"fact":"round","publisher":"crunchbase","retrievedAt":"2026-06-05","status":"attributed","url":null},{"fact":"existence","publisher":"neuron23.com","retrievedAt":"2026-06-05","status":"self-reported","url":"https://neuron23.com"},{"fact":"description","publisher":"neuron23.com","retrievedAt":"2026-06-05","status":"self-reported","url":"https://neuron23.com"}],"stage":"series-b+","stockCard":{"asOf":"2026-11-09","facts":[],"generatedAt":"2026-11-09","state":"insufficient-evidence","tldr":[]},"techStack":["adobe fonts","cloudflare","cloudflare bot management","contact form 7 6.1.6","doubleclick floodlight","google analytics","google tag manager","hsts","http/3","jquery migrate 3.4.1","jsdelivr","recaptcha"],"totalRaisedUsd":310000000,"traction":[],"updatedAt":"2026-06-05","valuations":[]}